Jim Jones, the former head of the FDA who resigned earlier this month, said the agency's layoffs show that the current administration is unserious.

Zipalertinib pivotal Phase 2b study met primary endpoint; full results mid-year 2025 and NDA submission planned H2 2025, ...

Google on Tuesday received clearance from the U.S. Food and Drug Administration for the Pixel Watch 3's Loss of Pulse ...

The cancelation comes as the United States is in the midst of a particularly severe flu season. So far, there have been 86 deaths in children and 19,000 deaths in adults this season, according to data ...

A government advisory committee has canceled a meeting on flu shot recommendations, raising concerns amid shifts in ...

BOSTON, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today reported financial results for the fourth quarter and full year ended December 31, 2024 and highlighted recent ...